Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Wei-Ming  [Clear All Filters]
2023
Yang S, Zhang X, Gale RPeter, Du X, Chen C-Y, Weng J-Y, Huang J, Li F, Zeng Y, Xiao Z, et al. Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. Am J Hematol. 2023.
2020
Li Y-Y, Xu Q-W, Xu P-Y, Li W-M. MSC-derived exosomal miR-34a/c-5p and miR-29b-3p improve intestinal barrier function by targeting the Snail/Claudins signaling pathway. Life Sci. 2020:118017.
Yeh B-W, Yu L-E, Li C-C, Yang J-C, Li W-M, Wu Y-C, Wei Y-C, Lee H-T, Kung M-L, Wu W-J. The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy. Toxicol Appl Pharmacol. 2020:115129.
2015
Yeh H-C, Jan H-C, Wu W-J, Li C-C, Li W-M, Ke H-L, Huang S-P, Liu C-C, Lee Y-C, Yang S-F, et al. Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma. PLoS One. 2015;10(10):e0139624.
Yeh H-C, Li C-C, Huang C-N, Hour T-C, Yeh B-W, Li W-M, Liang P-I, Chang L-L, Li C-F, Wu W-J. PTP4A3 independently predicts metastasis and survival in upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2015.
2013
Zhong Z-D, Li L, Wu Y-H, You Y, Li W-M, Zou P. Analysis of seizure risk factors after allogeneic hematopoietic stem cell transplantation: A 8 case report and literature review. J Huazhong Univ Sci Technolog Med Sci. 2013;33(5):656-660.